Ahead of PTC Therapeutics (PTCT) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Wall Street analysts expect PTC Therapeutics (PTCT) to post quarterly loss of -$0.21 per share in its upcoming report, which indicates a year-over-year increase of 12.5%. Revenues are expected to be $304.72 million, up 42.9% from the year-ago quarter.The current level reflects an upward revision of 15.3% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Prior to a ...